Medical devices, healthcare technology and the business of care
PMA approval · P230020

Altius Direct Electrical Nerve Stimulation System

Neuros Medical, Inc. · Decision date Aug 26, 2024

FDA DECISIONP230020

What did the FDA approve?

FDA records P230020 as an original PMA application. The recorded decision is approval, dated Aug 26, 2024.

FDA approval order statement

Approval order for Altius Direct Electrical Nerve Stimulation System. This device is indicated as an aid in the management of chronic intractable phantom and residual lower limb post-amputation pain in adult amputees.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Aug 26, 2024

FDA source record

Regulatory record facts

Identifier
P230020
Regulatory pathway
Premarket approval application
Product code
SAZ
Decision code
APPR
Decision date
Aug 26, 2024
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: stimulator, nerve terminus, totally implanted for chronic intractable post-amputation pain of the lower limb.

Product code
SAZ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P230020 received

    Application receipt date recorded by FDA.

  2. P230020 · FDA decision

    APPR

  3. P230020/S011 · Related supplement

    Altius Direct Electrical Nerve Stimulation System

Timeline entries are records held by MedtechLedger for P230020. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230020

Product / regulatory recordCompanyPathwayDecision dateSource
Neuros Medical, Inc.PMA supplementOct 16, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Neuros Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
26800 Aliso Viejo Pkwy., Suite 250, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records